Mathes Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$646K Buy
2,641
+658
+33% +$153K 0.24% 68
2025
Q4
$410K Hold
1,983
0.15% 93
2025
Q3
$368K Sell
1,983
-60
-3% -$10.3K 0.13% 99
2025
Q2
$312K Hold
2,043
0.12% 108
2025
Q1
$339K Sell
2,043
-1,542
-43% -$241K 0.14% 104
2024
Q4
$518K Sell
3,585
-16,410
-82% -$2.54M 0.19% 85
2024
Q3
$3.24M Sell
19,995
-54
-0.3% -$8.6K 1.14% 31
2024
Q2
$2.93M Hold
20,049
1.06% 32
2024
Q1
$3.17M Sell
20,049
-62
-0.3% -$9.87K 1.19% 30
2023
Q4
$3.15M Sell
20,111
-129
-0.6% -$19.8K 1.3% 26
2023
Q3
$3.15M Buy
20,240
+81
+0.4% +$13.4K 1.46% 25
2023
Q2
$3.34M Buy
+20,159
New +$3.25M 1.46% 22
2022
Q4
$3.57M Sell
20,214
-45
-0.2% -$7.77K 1.8% 14
2022
Q3
$3.31M Sell
20,259
-75
-0.4% -$12.7K 1.85% 12
2022
Q2
$3.61M Sell
20,334
-430
-2% -$76.6K 1.75% 11
2022
Q1
$3.68M Sell
20,764
-900
-4% -$153K 1.43% 21
2021
Q4
$3.71M Sell
21,664
-300
-1% -$49.1K 1.27% 30
2021
Q3
$3.55M Sell
21,964
-900
-4% -$154K 1.32% 32
2021
Q2
$3.77M Sell
22,864
-615
-3% -$102K 1.36% 33
2021
Q1
$3.86M Sell
23,479
-113
-0.5% -$18.3K 1.49% 23
2020
Q4
$3.71M Buy
23,592
+550
+2% +$81.2K 1.51% 24
2020
Q3
$3.43M Sell
23,042
-1,550
-6% -$229K 1.6% 19
2020
Q2
$3.46M Sell
24,592
-1,120
-4% -$163K 1.72% 18
2020
Q1
$3.37M Sell
25,712
-2,030
-7% -$288K 2.24% 10
2019
Q4
$4.05M Sell
27,742
-685
-2% -$92.9K 1.89% 13
2019
Q3
$3.68M Sell
28,427
-350
-1% -$46.1K 1.9% 14
2019
Q2
$4.01M Sell
28,777
-125
-0.4% -$17.3K 2.12% 8
2019
Q1
$4.04M Sell
28,902
-1,960
-6% -$263K 2.06% 6
2018
Q4
$3.98M Sell
30,862
-980
-3% -$137K 2.51% 5
2018
Q3
$4.4M Sell
31,842
-2,685
-8% -$357K 2.05% 9
2018
Q2
$4.19M Buy
34,527
+1,885
+6% +$235K 2% 12
2018
Q1
$4.18M Sell
32,642
-3,735
-10% -$505K 1.95% 14
2017
Q4
$5.08M Buy
36,377
+700
+2% +$97.5K 2.33% 11
2017
Q3
$4.64M Sell
35,677
-315
-0.9% -$41.8K 2.18% 10
2017
Q2
$4.76M Buy
35,992
+335
+0.9% +$42.7K 2.28% 10
2017
Q1
$4.44M Sell
35,657
-50
-0.1% -$5.97K 2.36% 10
2016
Q4
$4.11M Sell
35,707
-6,975
-16% -$806K 2.27% 10
2016
Q3
$5.04M Buy
42,682
+5,540
+15% +$672K 2.86% 6
2016
Q2
$4.5M Buy
37,142
+115
+0.3% +$13.1K 2.63% 6
2016
Q1
$4.01M Sell
37,027
-1,775
-5% -$184K 2.41% 7
2015
Q4
$3.99M Sell
38,802
-450
-1% -$45.3K 2.26% 6
2015
Q3
$3.66M Sell
39,252
-375
-0.9% -$36.3K 2.42% 7
2015
Q2
$3.86M Hold
39,627
2.06% 8
2015
Q1
$3.99M Hold
39,627
2.05% 7
2014
Q4
$4.14M Sell
39,627
-787
-2% -$82.9K 2.17% 7
2014
Q3
$4.31M Buy
40,414
+30
+0.1% +$3.11K 2.17% 8
2014
Q2
$4.22M Buy
40,384
+660
+2% +$66.7K 2.09% 7
2014
Q1
$3.9M Sell
39,724
-4,100
-9% -$380K 2.09% 7
2013
Q4
$4.01M Buy
43,824
+12,975
+42% +$1.2M 2.16% 6
2013
Q3
$2.67M Hold
30,849
2.55% 7
2013
Q2
$2.65M Buy
+30,849
New +$2.62M 2.88% 5

Other funds holding JNJ

Mathes Company's JNJ Position: Q1 2026 in Review

Mathes Company increased its Johnson & Johnson (JNJ) stake by 33% in Q1 2026, buying an estimated $153K and bringing the position to 2,641 shares worth $646K. The position accounts for 0.24% of the portfolio, ranked #68.

Mathes Company first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.08M in Q4 2017. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Mathes Company held 2,641 shares of Johnson & Johnson worth $646K as of Q1 2026.
  • Mathes Company bought 658 Johnson & Johnson shares in Q1 2026, an estimated $153K.
  • Johnson & Johnson made up 0.24% of Mathes Company's portfolio in Q1 2026, its #68 holding.
  • Mathes Company first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • Mathes Company's Johnson & Johnson position peaked at $5.08M in Q4 2017.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Mathes Company's 13F filing for Q1 2026, filed 8 May 2026.